Regen BioPharma

Regen BioPharma Focuses on the Development of Regenerative Medicine Applications in the Stem Cell Field. Regen BioPharma is a publicly traded biotechnology company that focuses on the fields of immunology and immunotherapy. The company plans to rapidly advance new technologies through preclinical and Phase I/II clinical trials. Currently, the company is advancing small molecule therapies for the treatment of cancer and autoimmune diseases by modulating the target NR2F6.